Anavex Life Sciences (AVXL) – FDA
-
Anavex Life Sciences (AVXL) Reports Publication Confirming Pharmacokinetic Dose Proportionality of ANAVEX3-71 in Humans
-
Anavex Life Sciences (AVXL) Announces Phase 2 Trial of ANAVEX3-71 in Schizophrenia
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AVXL Stock Lookup